Document Detail

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.
MedLine Citation:
PMID:  23287624     Owner:  NLM     Status:  In-Data-Review    
High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.
Bob Löwenberg
Related Documents :
24306184 - Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary a...
23843834 - Recombinant tsh and lithium overcomes amiodarone-induced low radioiodine uptake in a th...
19133094 - Ex vivo antimicrobial activity of several bleaching agents used during the walking blea...
10974404 - Effects of octreotide, a somatostatin analogue, on initiation of pancreatic carcinogene...
21661414 - Effects of dexamethasone on ischemia reperfusion injury following pringle maneuver.
24306184 - Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Blood     Volume:  121     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  26-8     Citation Subset:  AIM; IM    
Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of celiac disease and cerebral venous thrombosis: Report of two cases.
Next Document:  Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a l...